30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Spectrum Pharmaceuticals Inc (SPPI)

Track

Stock chart
Ticker: SPPI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Bradrick Brittany
Director
1 sale — total 12,232 USD
Proposed sale 23 Jun 2023
Value US$1,007,594.79 | Price 461.63 | Shares 555
Planned sale 26 May 2023
Value US$3,489,468.88 | Price 138.39 | Shares 20,878
Proposed sale 26 May 2023
Value US$2,662,763.29 | Price 343.69 | Shares 56,626
Planned sale 15 Mar 2023
Value US$24,979.28 | Price 0.80 | Shares 31,381
Proposed sale 15 Mar 2023
Value US$24,988.69 | Price 0.80 | Shares 31,381
Planned sale 15 Mar 2023
Value US$21,648.81 | Price 0.80 | Shares 27,197
Planned sale 14 Mar 2023
Value US$14,867.31 | Price 0.82 | Shares 18,153
Proposed sale 14 Mar 2023
Value US$14,870.94 | Price 0.82 | Shares 18,153
Planned sale 14 Mar 2023
Value US$12,885.33 | Price 0.82 | Shares 15,733
Proposed sale 14 Mar 2023
Value US$12,888.47 | Price 0.82 | Shares 15,733
Planned sale 23 Feb 2023
Value US$14,156.45 | Price 0.77 | Shares 18,385
Planned sale 22 Feb 2023
Value US$9,124.39 | Price 0.76 | Shares 11,990
Planned sale 22 Feb 2023
Value US$17,249.54 | Price 0.77 | Shares 22,402
Planned sale 22 Feb 2023
Value US$11,115.93 | Price 0.76 | Shares 14,607
Planned sale 31 Jan 2023
Value US$25,428.68 | Price 0.62 | Shares 41,014
Planned sale 31 Jan 2023
Value US$70,899.84 | Price 0.66 | Shares 107,424
Planned sale 30 Jan 2023
Value US$14,219.07 | Price 0.54 | Shares 26,138
Planned sale 30 Jan 2023
Value US$37,747.62 | Price 0.54 | Shares 69,389
Planned sale 3 Jan 2023
Value US$9,140.88 | Price 0.38 | Shares 23,929
Buy 30 Nov 2022
Value US$22,500.00 | Price 0.45 | Shares 50,000
Planned sale 23 Jun 2022
Value US$5,593.61 | Price 0.84 | Shares 6,667
Planned sale 22 Jun 2022
Value US$4,913.38 | Price 0.81 | Shares 6,096
Planned sale 21 Jun 2022
Value US$2,801.66 | Price 0.79 | Shares 3,569
Planned sale 21 Jun 2022
Value US$4,483.14 | Price 0.79 | Shares 5,711
Planned sale 21 Jun 2022
Value US$3,362.16 | Price 0.79 | Shares 4,283
Planned sale 21 Jun 2022
Value US$3,362.16 | Price 0.79 | Shares 4,283
Planned sale 5 Apr 2022
Value US$1,927.47 | Price 1.41 | Shares 1,367
Planned sale 4 Apr 2022
Value US$1,626.75 | Price 1.35 | Shares 1,205
Planned sale 16 Mar 2022
Value US$11,520.51 | Price 0.71 | Shares 16,318
Planned sale 16 Mar 2022
Value US$13,293.27 | Price 0.71 | Shares 18,829
Planned sale 16 Mar 2022
Value US$17,724.13 | Price 0.71 | Shares 25,105
Planned sale 16 Mar 2022
Value US$11,520.51 | Price 0.71 | Shares 16,318
Planned sale 15 Mar 2022
Value US$14,560.36 | Price 0.71 | Shares 20,653
Planned sale 15 Mar 2022
Value US$14,350.98 | Price 0.71 | Shares 20,356
Planned sale 15 Mar 2022
Value US$17,716.65 | Price 0.71 | Shares 25,130
Planned sale 15 Mar 2022
Value US$10,333.89 | Price 0.71 | Shares 14,658
Planned sale 24 Feb 2022
Value US$9,619.84 | Price 0.64 | Shares 15,031
Planned sale 24 Feb 2022
Value US$9,413.12 | Price 0.64 | Shares 14,708
Planned sale 24 Feb 2022
Value US$11,802.24 | Price 0.64 | Shares 18,441
Planned sale 24 Feb 2022
Value US$10,213.12 | Price 0.64 | Shares 15,958
Planned sale 23 Feb 2022
Value US$9,499.64 | Price 0.70 | Shares 13,513
Planned sale 23 Feb 2022
Value US$9,466.60 | Price 0.70 | Shares 13,466
Planned sale 23 Feb 2022
Value US$14,026.96 | Price 0.70 | Shares 19,953
Planned sale 23 Feb 2022
Value US$14,211.14 | Price 0.70 | Shares 20,215
Planned sale 9 Nov 2021
Value US$13,080.00 | Price 2.18 | Shares 6,000
Planned sale 8 Nov 2021
Value US$16,220.69 | Price 2.20 | Shares 7,363
Planned sale 23 Jun 2021
Value US$20,000.00 | Price 4.00 | Shares 5,000
Planned sale 22 Jun 2021
Value US$23,784.61 | Price 4.09 | Shares 5,821
Planned sale 22 Jun 2021
Value US$18,720.00 | Price 4.16 | Shares 4,500
Planned sale 21 Jun 2021
Value US$15,933.51 | Price 4.27 | Shares 3,735
Planned sale 18 Jun 2021
Value US$38,160.00 | Price 4.24 | Shares 9,000
Planned sale 14 May 2021
Value US$6,907.50 | Price 3.07 | Shares 2,250
Planned sale 14 May 2021
Value US$1,611.75 | Price 3.07 | Shares 525
Planned sale 13 May 2021
Value US$10,498.57 | Price 3.09 | Shares 3,402
Planned sale 13 May 2021
Value US$1,339.32 | Price 3.09 | Shares 434
Planned sale 1 Apr 2021
Value US$7,260.00 | Price 3.30 | Shares 2,200
Planned sale 31 Mar 2021
Value US$5,564.80 | Price 3.20 | Shares 1,739
Planned sale 16 Mar 2021
Value US$69,475.32 | Price 3.69 | Shares 18,828
Planned sale 16 Mar 2021
Value US$60,213.42 | Price 3.69 | Shares 16,318
Planned sale 16 Mar 2021
Value US$104,216.67 | Price 3.69 | Shares 28,243
Planned sale 16 Mar 2021
Value US$60,213.42 | Price 3.69 | Shares 16,318
Planned sale 16 Mar 2021
Value US$69,475.32 | Price 3.69 | Shares 18,828
Planned sale 15 Mar 2021
Value US$82,037.38 | Price 3.63 | Shares 22,631
Planned sale 15 Mar 2021
Value US$73,823.12 | Price 3.63 | Shares 20,365
Planned sale 15 Mar 2021
Value US$145,329.88 | Price 3.63 | Shares 40,091
Planned sale 15 Mar 2021
Value US$52,062.25 | Price 3.63 | Shares 14,362
Planned sale 15 Mar 2021
Value US$84,429.88 | Price 3.63 | Shares 23,291
Planned sale 22 Feb 2021
Value US$14,920.00 | Price 3.73 | Shares 4,000
Planned sale 22 Feb 2021
Value US$14,920.00 | Price 3.73 | Shares 4,000
Planned sale 22 Feb 2021
Value US$18,650.00 | Price 3.73 | Shares 5,000
Planned sale 22 Feb 2021
Value US$27,975.00 | Price 3.73 | Shares 7,500
Planned sale 19 Feb 2021
Value US$16,992.06 | Price 3.64 | Shares 4,672
Planned sale 19 Feb 2021
Value US$11,983.92 | Price 3.64 | Shares 3,295
Planned sale 19 Feb 2021
Value US$18,250.47 | Price 3.64 | Shares 5,018
Planned sale 19 Feb 2021
Value US$26,393.71 | Price 3.64 | Shares 7,257
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-23 2023-06-23 PrS Proposed sale
Bradrick Brittany

Director

Non-Executive Director
555
461.63
US$1,007,595 		555 461.63 US$1,007,595
2023-05-30 2023-05-26 PlS Planned sale
Brennan Nora

CFO

Officer
20,878 +31.8%
138.39
US$3,489,469 		20,878 +31.8% 138.39 US$3,489,469
2023-05-26 2023-05-26 PrS Proposed sale
Brennan Nora

Officer

Officer
56,626
343.69
US$2,662,763 		56,626 343.69 US$2,662,763
2023-03-17 2023-03-15 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
31,381 -6.2%
0.80
US$24,979 		31,381 -6.2% 0.80 US$24,979
2023-03-17 2023-03-15 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
27,197 -12.6%
0.80
US$21,649 		27,197 -12.6% 0.80 US$21,649
2023-03-15 2023-03-15 PrS Proposed sale
Riga Thomas J

Officer; Director

Executive Director
31,381
0.80
US$24,989 		31,381 0.80 US$24,989
2023-03-17 2023-03-14 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
18,153 -3.5%
0.82
US$14,867 		18,153 -3.5% 0.82 US$14,867
2023-03-17 2023-03-14 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
15,733 -6.8%
0.82
US$12,885 		15,733 -6.8% 0.82 US$12,885
2023-03-14 2023-03-14 PrS Proposed sale
McGahan Keith M

Officer

Officer
15,733
0.82
US$12,888 		15,733 0.82 US$12,888
2023-03-14 2023-03-14 PrS Proposed sale
Riga Thomas J

Officer

Officer
18,153
0.82
US$14,871 		18,153 0.82 US$14,871
2023-02-24 2023-02-23 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
18,385 -2.9%
0.77
US$14,156 		18,385 -2.9% 0.77 US$14,156
2023-02-24 2023-02-22 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
11,990 -1.8%
0.76
US$9,124 		11,990 -1.8% 0.76 US$9,124
2023-02-24 2023-02-22 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
22,402 -1.2%
0.77
US$17,250 		22,402 -1.2% 0.77 US$17,250
2023-02-24 2023-02-22 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
14,607 -0.8%
0.76
US$11,116 		14,607 -0.8% 0.76 US$11,116
2023-02-01 2023-01-31 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
41,014 -6.0%
0.62
US$25,429 		41,014 -6.0% 0.62 US$25,429
2023-02-01 2023-01-31 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
107,424 -5.3%
0.66
US$70,900 		107,424 -5.3% 0.66 US$70,900
2023-02-01 2023-01-30 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
26,138 -3.7%
0.54
US$14,219 		26,138 -3.7% 0.54 US$14,219
2023-02-01 2023-01-30 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
69,389 -3.3%
0.54
US$37,748 		69,389 -3.3% 0.54 US$37,748
2023-01-05 2023-01-03 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
23,929 -2.0%
0.38
US$9,141 		23,929 -2.0% 0.38 US$9,141
2022-12-02 2022-11-30 B Purchase
2.6
Vacirca Jeff L
Non-Executive Director
50,000 +22.7%
0.45
US$22,500 		50,000 +22.7% 0.45 US$22,500
2022-06-23 2022-06-23 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
6,667 -1.0%
0.84
US$5,594 		6,667 -1.0% 0.84 US$5,594
2022-06-23 2022-06-22 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
6,096 -0.9%
0.81
US$4,913 		6,096 -0.9% 0.81 US$4,913
2022-06-23 2022-06-21 PlS Planned sale
Brennan Nora

EVP & CFO

Officer
3,569 -1.0%
0.79
US$2,802 		3,569 -1.0% 0.79 US$2,802
2022-06-22 2022-06-21 PlS Planned sale
Fischer Seth H. Z.
Non-Executive Director
5,711 -16.4%
0.79
US$4,483 		5,711 -16.4% 0.79 US$4,483
2022-06-22 2022-06-21 PlS Planned sale
Ashton William
Non-Executive Director
4,283 -9.1%
0.79
US$3,362 		4,283 -9.1% 0.79 US$3,362
2022-06-22 2022-06-21 PlS Planned sale
2.3
Vyas Dolatrai

Former Director
4,283 -5.0%
0.79
US$3,362 		4,283 -5.0% 0.79 US$3,362
2022-04-05 2022-04-05 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
1,367 -0.5%
1.41
US$1,927 		1,367 -0.5% 1.41 US$1,927
2022-04-05 2022-04-04 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
1,205 -0.5%
1.35
US$1,627 		1,205 -0.5% 1.35 US$1,627
2022-03-16 2022-03-16 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
16,318 -4.9%
0.71
US$11,521 		16,318 -4.9% 0.71 US$11,521
2022-03-16 2022-03-16 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
18,829 -3.2%
0.71
US$13,293 		18,829 -3.2% 0.71 US$13,293
2022-03-16 2022-03-16 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
25,105 -9.0%
0.71
US$17,724 		25,105 -9.0% 0.71 US$17,724
2022-03-16 2022-03-16 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
16,318 -6.2%
0.71
US$11,521 		16,318 -6.2% 0.71 US$11,521
2022-03-16 2022-03-15 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
20,653 -5.8%
0.71
US$14,560 		20,653 -5.8% 0.71 US$14,560
2022-03-16 2022-03-15 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
20,356 -3.3%
0.71
US$14,351 		20,356 -3.3% 0.71 US$14,351
2022-03-16 2022-03-15 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
25,130 -8.2%
0.71
US$17,717 		25,130 -8.2% 0.71 US$17,717
2022-03-16 2022-03-15 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
14,658 -5.3%
0.71
US$10,334 		14,658 -5.3% 0.71 US$10,334
2022-02-24 2022-02-24 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
15,031 -5.2%
0.64
US$9,620 		15,031 -5.2% 0.64 US$9,620
2022-02-24 2022-02-24 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
14,708 -4.6%
0.64
US$9,413 		14,708 -4.6% 0.64 US$9,413
2022-02-24 2022-02-24 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
18,441 -2.9%
0.64
US$11,802 		18,441 -2.9% 0.64 US$11,802
2022-02-24 2022-02-24 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
15,958 -4.3%
0.64
US$10,213 		15,958 -4.3% 0.64 US$10,213
2022-02-24 2022-02-23 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
13,513 -4.4%
0.70
US$9,500 		13,513 -4.4% 0.70 US$9,500
2022-02-24 2022-02-23 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
13,466 -4.0%
0.70
US$9,467 		13,466 -4.0% 0.70 US$9,467
2022-02-24 2022-02-23 PlS Planned sale
Riga Thomas J

CEO & President

Executive Director
19,953 -3.1%
0.70
US$14,027 		19,953 -3.1% 0.70 US$14,027
2022-02-24 2022-02-23 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
20,215 -5.2%
0.70
US$14,211 		20,215 -5.2% 0.70 US$14,211
2021-11-10 2021-11-09 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
6,000 -1.8%
2.18
US$13,080 		6,000 -1.8% 2.18 US$13,080
2021-11-10 2021-11-08 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
7,363 -2.1%
2.20
US$16,221 		7,363 -2.1% 2.20 US$16,221
2021-06-23 2021-06-23 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
5,000 -1.4%
4.00
US$20,000 		5,000 -1.4% 4.00 US$20,000
2021-06-23 2021-06-22 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
5,821 -1.7%
4.09
US$23,785 		5,821 -1.7% 4.09 US$23,785
2021-06-22 2021-06-22 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
4,500 -1.5%
4.16
US$18,720 		4,500 -1.5% 4.16 US$18,720
2021-06-22 2021-06-21 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
3,735 -1.2%
4.27
US$15,934 		3,735 -1.2% 4.27 US$15,934
2021-06-22 2021-06-18 PlS Planned sale
2.3
Vyas Dolatrai
Non-Executive Director
9,000 -9.4%
4.24
US$38,160 		9,000 -9.4% 4.24 US$38,160
2021-05-14 2021-05-14 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
2,250 -0.5%
3.07
US$6,908 		2,250 -0.5% 3.07 US$6,908
2021-05-14 2021-05-14 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
525 -0.2%
3.07
US$1,612 		525 -0.2% 3.07 US$1,612
2021-05-14 2021-05-13 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
3,402 -0.8%
3.09
US$10,499 		3,402 -0.8% 3.09 US$10,499
2021-05-14 2021-05-13 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
434 -0.1%
3.09
US$1,339 		434 -0.1% 3.09 US$1,339
2021-04-01 2021-04-01 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
2,200 -0.7%
3.30
US$7,260 		2,200 -0.7% 3.30 US$7,260
2021-04-01 2021-03-31 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
1,739 -0.5%
3.20
US$5,565 		1,739 -0.5% 3.20 US$5,565
2021-03-17 2021-03-16 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
18,828 -5.1%
3.69
US$69,475 		18,828 -5.1% 3.69 US$69,475
2021-03-17 2021-03-16 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
16,318 -3.9%
3.69
US$60,213 		16,318 -3.9% 3.69 US$60,213
2021-03-17 2021-03-16 PlS Planned sale
Turgeon Joseph W.

CEO & President

Executive Director
28,243 -4.8%
3.69
US$104,217 		28,243 -4.8% 3.69 US$104,217
2021-03-17 2021-03-16 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
16,318 -4.9%
3.69
US$60,213 		16,318 -4.9% 3.69 US$60,213
2021-03-17 2021-03-16 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
18,828 -4.4%
3.69
US$69,475 		18,828 -4.4% 3.69 US$69,475
2021-03-17 2021-03-15 PlS Planned sale
LEBEL FRANCOIS

Chief Medical Officer

Officer
22,631 -5.7%
3.63
US$82,037 		22,631 -5.7% 3.63 US$82,037
2021-03-17 2021-03-15 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
20,365 -4.7%
3.63
US$73,823 		20,365 -4.7% 3.63 US$73,823
2021-03-17 2021-03-15 PlS Planned sale
Turgeon Joseph W.

CEO & President

Executive Director
40,091 -6.3%
3.63
US$145,330 		40,091 -6.3% 3.63 US$145,330
2021-03-17 2021-03-15 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
14,362 -4.1%
3.63
US$52,062 		14,362 -4.1% 3.63 US$52,062
2021-03-17 2021-03-15 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
23,291 -5.1%
3.63
US$84,430 		23,291 -5.1% 3.63 US$84,430
2021-02-23 2021-02-22 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
4,000 -0.9%
3.73
US$14,920 		4,000 -0.9% 3.73 US$14,920
2021-02-23 2021-02-22 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
4,000 -1.1%
3.73
US$14,920 		4,000 -1.1% 3.73 US$14,920
2021-02-23 2021-02-22 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
5,000 -1.1%
3.73
US$18,650 		5,000 -1.1% 3.73 US$18,650
2021-02-23 2021-02-22 PlS Planned sale
Turgeon Joseph W.

CEO & President

Executive Director
7,500 -1.2%
3.73
US$27,975 		7,500 -1.2% 3.73 US$27,975
2021-02-23 2021-02-19 PlS Planned sale
3.4
GUSTAFSON KURT A

EVP & Chief Financial Officer

Officer
4,672 -1.0%
3.64
US$16,992 		4,672 -1.0% 3.64 US$16,992
2021-02-23 2021-02-19 PlS Planned sale
McGahan Keith M

Chief Legal Officer

Officer
3,295 -0.9%
3.64
US$11,984 		3,295 -0.9% 3.64 US$11,984
2021-02-23 2021-02-19 PlS Planned sale
Riga Thomas J

EVP, COO & CCO

Officer
5,018 -1.1%
3.64
US$18,250 		5,018 -1.1% 3.64 US$18,250
2021-02-23 2021-02-19 PlS Planned sale
Turgeon Joseph W.

CEO & President

Executive Director
7,257 -1.1%
3.64
US$26,394 		7,257 -1.1% 3.64 US$26,394
Explore more

More insider trading research around Spectrum Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America